Hexavalent vaccine could improve India’s immunisation programme: Study
A new study suggests that integrating a hexavalent vaccine into India's Universal Immunisation Programme could significantly improve efficiency and reduce the burden on healthcare workers. The vaccine combines protection against six diseases into a single injection, potentially saving costs if procurement prices are reduced.
Why it matters
Adopting this vaccine could streamline public health logistics and improve vaccination coverage for millions of infants across India.
Introducing the hexavalent (six-in-one) vaccine into India’s Universal Immunisation Programme (UIP) could improve the efficiency of the country’s childhood immunisation programme, according to a study conducted by the Union Health Ministry along with the George Institute for Global Health India, the Gates Foundation, Gavi, the Vaccine Alliance, and John Snow India Private Limited.
A hexavalent (six-in-one) vaccine is a combination vaccine that protects infants against diphtheria, tetanus, pertussis (whooping cough), Hepatitis B, Haemophilus influenzae type b (Hib), and polio in a single injection. It reduces the number of injections children need, eases the workload of frontline health workers, lowers cold-chain requirements, and saves caregivers’ time.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in